4-82917201-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024672.6(THAP9):āc.989T>Gā(p.Phe330Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,614,162 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_024672.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
THAP9 | NM_024672.6 | c.989T>G | p.Phe330Cys | missense_variant | 5/5 | ENST00000302236.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
THAP9 | ENST00000302236.10 | c.989T>G | p.Phe330Cys | missense_variant | 5/5 | 1 | NM_024672.6 | P1 | |
THAP9 | ENST00000505901.1 | c.*746T>G | 3_prime_UTR_variant, NMD_transcript_variant | 6/6 | 2 | ||||
LIN54 | ENST00000505905.1 | n.305-3760A>C | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152232Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251352Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135846
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461812Hom.: 0 Cov.: 67 AF XY: 0.0000234 AC XY: 17AN XY: 727204
GnomAD4 genome AF: 0.000210 AC: 32AN: 152350Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74512
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 22, 2023 | The c.989T>G (p.F330C) alteration is located in exon 5 (coding exon 5) of the THAP9 gene. This alteration results from a T to G substitution at nucleotide position 989, causing the phenylalanine (F) at amino acid position 330 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at